High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center StudyLingdi Zhao, Quanli Gao, Tiepeng Li et al.|Frontiers in Immunology|2022Cited by 15
Generation of TALEN-mediated FH knockout rat modelDandan Yu, Zhenhe Suo, Long Yuan et al.|Oncotarget|2016Cited by 14
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancerBaozhen Ma, Quanli Gao, Yu Zhou et al.|Frontiers in Oncology|2022Cited by 5
Clinical Efficacy of Autologous CIK Cell Adoptive Immunotherapy Combined with Chemotherapy inPatients Withmetastatic Renal Cell CarcinomaWang Li, Yongping Song, Gao Quan-li et al.|Zhongliu fangzhi yanjiu|2012Cited by 0